All Stories

  1. Proinflammatory phenotype can be critical in defining and modulating the genetic risk of non-syndromic hearing loss
  2. Pharmacoepigenomic Impact of Antihypertensive Drugs on miRNome and Proteome and Its Potential Influence on Health and Side Effects
  3. Integrated Pharmacoepigenomic Analysis Uncovers the Impact of Antiseizure Medications on Developmental Pathways and the Protective Effect of Folic Acid
  4. Shared genetic architecture of stroke and its comorbid conditions reveals latent phenotypes that differ among populations: A genomic structural equation modelling approach
  5. Neur-Ally: a deep learning model for regulatory variant prediction based on genomic and epigenomic features in brain and its validation in certain neurological disorders
  6. AGAAT: Automated computational tool integrating different genotyping array and correctional methods for data analysis
  7. Neur-Ally: A deep learning model for regulatory variant prediction based on genomic and epigenomic features in brain and its validation in certain neurological disorders
  8. Ethnic and region-specific genetic risk variants of stroke and its comorbid conditions can define the variations in the burden of stroke and its phenotypic traits
  9. Ethnic and region-specific genetic risk variants of stroke and its comorbid conditions can define the variations in the burden of stroke and its phenotypic traits
  10. Ethnic and region-specific genetic risk variants of stroke and its comorbid conditions can define the variations in the burden of stroke and its phenotypic traits
  11. Comprehensive Genetic Study of a Monozygotic Triplet Discordant for Autism Spectrum Disorder
  12. Genetic Affinities and Adaptation of the South-West Coast Populations of India
  13. An interpretable block-attention network for identifying regulatory feature interactions
  14. Pharmacoepigenomics: A Key Determinant in Resolving Epigenomic Parameters in Pathogenesis and Treatment Response in Complex Diseases
  15. Genomic selection signatures in autism spectrum disorder identifies cognitive genomic tradeoff and its relevance in paradoxical phenotypes of deficits versus potentialities
  16. Epigenetic Alterations in Alzheimer’s Disease and Its Therapeutic and Dietary Interventions
  17. Pro-inflammatory cytokine response pre-dominates immuno-genetic pathway in development of rheumatoid arthritis
  18. Genetic gateways to COVID‐19 infection: Implications for risk, severity, and outcomes
  19. Methylation Map Genes Can be Critical in Determining the Methylome of Intracranial Aneurysm Patients
  20. Vessel Wall Thickening and Enhancement in High-Resolution Intracranial Vessel Wall Imaging: A Predictor of Future Ischemic Events in Moyamoya Disease
  21. An Immunological Perspective to Non-syndromic Sensorineural Hearing Loss
  22. Genetics of Epigenome Might Hold the Clue for Determining the Threshold of Environmental Impact
  23. Culture-independent studies on bacterial dysbiosis in oral and oropharyngeal squamous cell carcinoma: A systematic review
  24. Genetic association of DNMT variants can play a critical role in defining the methylation patterns in autism
  25. Pharmacoepigenetics of Antipsychotic Drugs
  26. Association of matrix metalloproteinase 2 and matrix metalloproteinase 9 gene polymorphism in aggressive and nonaggressive odontogenic lesions: A pilot study
  27. Understanding the role of genetic variability in LRRK2 in Indian population
  28. Impact of antipsychotic treatment on methylation status of Interleukin-6 [IL-6] gene in Schizophrenia
  29. Antipsychotic drugs can influence host epigenome
  30. Haloperidol induces pharmacoepigenetic response by modulating miRNA expression, global DNA methylation and expression profiles of methylation maintenance genes and genes involved in neurotransmission in neuronal cells
  31. Pharmacoepigenomic responses of antipsychotic drugs on pharmacogenes are likely to be modulated by miRNAs
  32. Understanding epigenetics of schizophrenia in the backdrop of its antipsychotic drug therapy
  33. Pharmaco-Epigenomic Response of Antipsychotic Drugs In Theranostics of Schizophrenia
  34. Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson’s disease patients
  35. Evaluation of salivary DNA obtained from dental prosthesis and its applicability in forensic investigations
  36. Pro-inflammatory cytokines and their epistatic interactions in genetic susceptibility to schizophrenia
  37. Erratum to: Pathogenesis of intracranial aneurysm is mediated by proinflammatory cytokine TNFA and IFNG and through stochastic regulation of IL10 and TGFB1 by comorbid factors
  38. Pathogenesis of intracranial aneurysm is mediated by proinflammatory cytokine TNFA and IFNG and through stochastic regulation of IL10 and TGFB1 by comorbid factors
  39. Association of Versican (VCAN) gene polymorphisms rs251124 and rs2287926 (G428D), with intracranial aneurysm
  40. DNA Methyl Transferase (DNMT) Gene Polymorphisms Could Be a Primary Event in Epigenetic Susceptibility to Schizophrenia
  41. Genetic Association Analysis of ATP Binding Cassette Protein Family Reveals a Novel Association of ABCB1 Genetic Variants with Epilepsy Risk, but Not with Drug-Resistance
  42. Circadian rhythm of homocysteine is hCLOCK genotype dependent
  43. Cytokine gene polymorphism (interleukin-1β +3954, Interleukin-6 [−597/−174] and tumor necrosis factor-α −308) in chronic periodontitis with and without type 2 diabetes mellitus
  44. Pharmacogenetic evaluation of ABCB1, Cyp2C9, Cyp2C19 and methylene tetrahydrofolate reductase polymorphisms in teratogenicity of anti-epileptic drugs in women with epilepsy
  45. Corrigendum to “Major vault protein (MVP) gene polymorphisms and drug resistance in mesial temporal lobe epilepsy with hippocampal sclerosis” [Gene 526 (2013) 449–453]
  46. GABRG2, rs211037 is associated with epilepsy susceptibility, but not with antiepileptic drug resistance and febrile seizures
  47. Lack of association of Lysyl oxidase (LOX) gene polymorphisms with intracranial aneurysm in a south Indian population
  48. Major vault protein (MVP) gene polymorphisms and drug resistance in mesial temporal lobe epilepsy with hippocampal sclerosis
  49. Association of Cytokine Gene Polymorphisms with Oral Lichen Planus in Malayalam-Speaking Ethnicity from South India (Kerala)
  50. Association of interleukin-4 and interleukin-17F polymorphisms in periodontitis in Dravidian ethnicity
  51. Failure to find association between febrile seizures and SCN1A rs3812718 polymorphism in south Indian patients with mesial temporal lobe epilepsy and hippocampal sclerosis
  52. Antipsychotic Drug Dosage and Therapeutic Response in Schizophrenia is Influenced by ABCB1 Genotypes: A Study from a South Indian Perspective
  53. Evidence for transforming Growth Factor-Beta 3 gene polymorphism in non-syndromic cleft lip and palate patients from Indian sub-continent
  54. Is pharmacogenomics a reality? Challenges and oppurtunities for India
  55. Drug resistance in epilepsy and the ABCB1 gene: The clinical perspective
  56. Corpora amylacea deposition in the hippocampus of patients with mesial temporal lobe epilepsy: A new role for an old gene?
  57. Transforming growth factor-β-1 polymorphisms are infrequent but exist at selected loci in oral submucous fibrosis
  58. Association of Single Nucleotide Gene Polymorphism at Interleukin‐1β +3954, −511, and −31 in Chronic Periodontitis and Aggressive Periodontitis in Dravidian Ethnicity
  59. Risk Factors for Aneurysmal Subarachnoid Hemorrhage in an Indian Population
  60. Evidence of association of serotonin transporter gene polymorphisms with schizophrenia in a South Indian population
  61. Analysis of Genotype and Haplotype Effects of ABCB1 (MDR1) Polymorphisms in the Risk of Medically Refractory Epilepsy in an Indian Population
  62. Universal protocol for generating 100bp size standard for endless usage
  63. Role of Endothelial Nitric Oxide Synthase Gene Polymorphisms in Predicting Aneurysmal Subarachnoid Hemorrhage in South Indian Patients
  64. Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population
  65. A Case‐Control Study on the Association of Human Leukocyte Antigen‐A*9 and ‐B*15 Alleles With Generalized Aggressive Periodontitis in an Indian Population
  66. A crypto‐Dravidian origin for the nontribal communities of South India based on human leukocyte antigen class I diversity
  67. Association of an Extended Haplotype of HLA Class I Alleles and Their Flanking Microsatellites with Spondyloarthropathies in South Indian Patients
  68. Lack of association of Endoglin insertion polymorphism in intracranial aneurysm in South Indian population
  69. Population dynamics of the Teak defoliator (Hyblaea puera Cramer) in Nilambur teak plantations using Randomly Amplified Gene Encoding Primers (RAGEP)
  70. HLA-A allele frequency and haplotype distribution in the dravidian tribal communities of south India
  71. HLA‐B and HLA‐C alleles and haplotypes in the Dravidian tribal populations of southern India
  72. Arylamine N-acetyltransferase 2 polymorphism in the ethnic populations of South India
  73. Genetic variation in Asiatic lions and Indian tigers